Dr Arthur Reingold | Professor And Division Head Epidemiology, Former Acip Member
UC Berkeley School of Public Health

Dr Arthur Reingold, Professor And Division Head Epidemiology, Former Acip Member, UC Berkeley School of Public Health

Arthur Reingold, MD is Professor of Epidemiology and Head of the Division of Epidemiology at the School of Public Health, University of California, Berkeley. Before joining the faculty of UC Berkeley in 1987, Dr. Reingold worked for eight years as a medical epidemiologist at the U.S. Centers for Disease Control and Prevention. Dr. Reingold is known nationally and internationally for his work over the past 30+ years on the prevention and control of infectious diseases, including those acquired from the environment (e.g. Legionnaires’ disease) and those transmitted from person-to-person (e.g. influenza and other causes of respiratory tract infections). His research collaborations nationally and internationally have led to almost 350 original research publications, which have appeared in the leading journals in the fields of medicine, epidemiology, infectious diseases, and public health. Because of his expertise and experience, he has served on numerous advisory committees and panels for the World Health Organization (e.g. the Strategic Advisory Group of Experts), NIH (e.g. the External Advisory Committee of the Fogarty International Center), and CDC (e.g. the Advisory Committee on Immunization Practices), as well as the State of California and diverse foundations and funding organizations. In recognition of his experience and expertise in epidemiology, Dr. Reingold has been elected President of the Society for Epidemiological Research (SER) and the American Epidemiology Society (AES) and elected to fellowship in diverse scientific and medical groups (e.g. the Infectious Diseases Society of American and the American Association for the Advancement of Science). He was elected to membership in the Institute of Medicine (now the National Academy of Medicine) in 2003 and has served on numerous IOM/NAM committees since that time. He has also given numerous invited lectures, including the Thomas Francis Lecture at the University of Michigan, and he regularly teaches courses on epidemiologic methods and their application at UC Berkeley and in Brazil, Hong Kong, and Switzerland. 


April 14 Pre-congress Workshop Day @ 10:00


Market access & regulatory challenges in vaccinesThe market access landscape for vaccines is more complex than most. Various obstacles are creating a disproportionate move away from investing in preventative interventions and vaccines. Learn how get optimal value for our vaccines and avoid the pit falls when launching a new vaccine.
  • What to do about Vaccine Hesitancy: When the “Facts” and the “Truth” are Discordant
  • Accurately capturing the full benefits of vaccines
  • HTA assessments around the world: What are the key attributes that drive decisions?
  • Regulatory and public health approaches to clinical trial design and interpretation
  • Value based contracting and managed entry agreements – Making sure uncertainties at launch do not hinder market access
  • Industry perspective: Navigating market authorization applications and life cycle management for new vaccines
  • The Gavi Alliance approach to increasing vaccine access in low-income countries; targeting “Healthy Markets” for vaccines in low-income countries
  • Group discussion and Q&A with audience
last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071